Nasdaq-listed Helius Medical Technologies has announced the launch of a $500 million corporate treasury reserve centered on Solana (SOL), marking one of the largest Solana-focused treasury initiatives to date. The company plans to build up its SOL holdings over the next 12–24 months, while also exploring staking and lending opportunities to maximize returns.
PIPE offering to fund crypto treasury
Helius priced an oversubscribed private investment in public equity (PIPE) offering at $6.88 per share, along with stapled warrants exercisable at $10.12 for three years. The deal includes $500 million in equity and up to $750 million in warrants, assuming full exercise.
The net proceeds from the offering will be used to establish a crypto treasury strategy, with SOL as the primary reserve asset. Helius said it plans to scale its holdings significantly over the next 12–24 months through capital markets programs including ATM sales and other proven strategies.
Strategic vision and market positioning
Helius intends to leverage the Solana ecosystem to generate additional revenue via staking and lending, while maintaining a conservative risk profile. The offering is led by Pantera Capital and Summer Capital, with other participants including Big Brain Holdings, Avenir, FalconX, Arrington Capital, Animoca Brands, and HashKey Capital. The PIPE is expected to close on September 18.
Helius emphasized that Solana is a “category-defining blockchain” and a foundation for the next generation of financial systems. Incoming executive chairman Joseph Chee noted that the new crypto treasury vehicle will focus on maximizing SOL per share, with capital markets transactions increasingly moving onto blockchain rails.